Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in CTO-PCI with ABSORB BVS
NCT02211066Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Oct 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in Chronic total occlusion of the coronary artery (CTO), sponsored by Hospital Clínic de Barcelona. Started Oct 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
Chronic total occlusion of the coronary artery (CTO)
Beyond the preview
Go deeper on NCT02211066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211066.